Takeda Pharmaceutical Company Limited announced new director assignments and the appointment of Julie Kim as Representative Director, President, and CEO. This leadership transition occurred as of the filing date, June 24, 2026. The company operates in the pharmaceutical industry, focusing on the development and manufacture of medicinal products.
